Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

428
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
428
Cross-reactivity00:42

Cross-reactivity

30.9K
Overview
30.9K
Antigen Processing Pathways01:31

Antigen Processing Pathways

862
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
862
Tumor Immunotherapy01:27

Tumor Immunotherapy

450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Antigen Presenting Cells01:22

Antigen Presenting Cells

1.6K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
1.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

617
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
617

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

Nature nanotechnology·2026
Same author

Fusogenic Polymer-Liposome-Hybrid Nanoparticle: A Versatile Platform for Synchronized Drug Delivery to the Cytoplasm and Cell Membrane.

Polymer science & technology (Washington, D.C.)·2026
Same author

Adjuvants orchestrate cross-organ induction of mucosal CD8+ T cell immune responses in respiratory tracts.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

Nature communications·2026
Same author

An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell-Mediated Anti-Tumor Immunity.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Next-generation inhibitors of SARS-CoV-2 M<sup>pro</sup> overcome the deficiencies of Paxlovid.

Nature communications·2026

Video Experimental Relacionado

Updated: May 20, 2025

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.7K

Las moléculas de orientación de ER basadas en agonistas de STING aumentan la presentación cruzada de antígenos

Xiafeng Wang1,2, Zhangping Huang2, Lixiao Xing3

  • 1Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Nature
|March 27, 2025
PubMed
Resumen

Los investigadores desarrollaron moléculas dirigidas a ER basadas en agonistas de STING (SABER) para mejorar las respuestas de las células T CD8+. Este nuevo sistema de administración se dirige al retículo endoplasmático, mejorando la eficacia de la vacuna contra tumores e infecciones.

Más Videos Relacionados

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.3K
Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
12:48

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation

Published on: August 21, 2017

8.2K

Videos de Experimentos Relacionados

Last Updated: May 20, 2025

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

9.7K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.3K
Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
12:48

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation

Published on: August 21, 2017

8.2K

Área de la Ciencia:

  • Inmunología
  • Vacunas y vacunas
  • Biología molecular

Sus antecedentes:

  • Las respuestas de las células T CD8+ son cruciales para combatir infecciones y tumores.
  • La presentación cruzada de antígenos en el retículo endoplasmático (ER) de las células dendríticas es clave para la inducción de células T CD8+.
  • Los métodos actuales de administración de antígenos carecen de precisión subcelular, particularmente para la vía citosol-ER.

Objetivo del estudio:

  • Desarrollar un nuevo sistema de administración de antígenos dirigido a ER.
  • Mejorar las respuestas inmunes de las células T CD8+ a través de una entrega subcelular precisa.
  • Investigar las propiedades auxiliares del sistema desarrollado.

Principales métodos:

  • Desarrollo de moléculas dirigidas a ER basadas en agonistas de STING (SABER).
  • Conjugación de SABER con varios antígenos (neoantígenos tumorales, epítopos virales).
  • Evaluación de la inducción de células T CD8+ y las respuestas inmunes en modelos preclínicos.
  • Evaluación del efecto adyuvante de SABER en un modelo de vacuna de subunidad del SARS-CoV-2.

Principales resultados:

  • SABER envía eficazmente antígenos a la sala de emergencias, formando así los microrreactores.
  • La conjugación con SABER mejora significativamente las respuestas de las células T CD8+ a los antígenos virales y tumorales.
  • SABER demuestra una eficacia superior en comparación con los adyuvantes convencionales o las mezclas antígeno/agonista.
  • SABER actúa como un potente adyuvante, mejorando las respuestas de neutralización de anticuerpos para una vacuna contra el SARS-CoV-2.

Conclusiones:

  • SABER representa un sistema de administración de alta afinidad dirigido a ER y un adyuvante de vacuna.
  • La entrega subcelular precisa a la maquinaria de presentación cruzada del ER permite avances significativos en el diseño de la vacuna.
  • Este enfoque ofrece un salto cualitativo en la inducción de una inmunidad robusta mediada por células T CD8+.